Koichiro Nozaki

Profile Information

Affiliation: Respiratory Medicine and Infectious Disease, Medical and Dental Hospital, Niigata University

Researcher number: 00827925
J-GLOBAL ID: 202101004538387443
researchmap Member ID: R000021925

Research Interests

Research Areas

Life sciences / Tumor diagnostics and therapeutics / Lung Cancer

Research History

Mar, 2018 - Present

病院専任助教, 呼吸器・感染症内科, 新潟大学医歯学総合病院

Education

Apr, 2011 - Mar, 2014

Niigata University
Apr, 2002 - Mar, 2008

School of Medicine, Faculty of Medicine, Niigata University

Awards

Sep, 2012

ESMO2012 poster award

Papers

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events

Toshiya Fujisaki, Satoshi Watanabe, Takeshi Ota, Kohei Kushiro, Yusuke Sato, Miho Takahashi, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Satoshi Hokari, Rie Kondo, Takao Miyabayashi, Tetsuya Abe, Satoru Miura, Hiroshi Tanaka, Masaaki Okajima, Masaki Terada, Naoya Matsumoto, Takashi Ishida, Akira Iwashima, Kazuhiro Sato, Hirohisa Yoshizawa, Nobumasa Aoki, Masachika Hayashi, Yasuyoshi Ohshima, Toshiyuki Koya, Toshiaki Kikuchi

Frontiers in Oncology, 11, Sep 24, 2021
Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease.

Yusuke Sato, Satoshi Watanabe, Takeshi Ota, Kohei Kushiro, Toshiya Fujisaki, Miho Takahashi, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Satoshi Hokari, Rie Kondo, Masachika Hayashi, Hiroyuki Ishikawa, Takao Miyabayashi, Tetsuya Abe, Satoru Miura, Hiroshi Tanaka, Masaaki Okajima, Masaki Terada, Takashi Ishida, Akira Iwashima, Kazuhiro Sato, Hirohisa Yoshizawa, Nobumasa Aoki, Yasuyoshi Ohshima, Toshiyuki Koya, Toshiaki Kikuchi

Translational lung cancer research, 10(7) 3132-3143, Jul, 2021
Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.

Satoshi Watanabe, Takeshi Ota, Masachika Hayashi, Hiroyuki Ishikawa, Aya Otsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Takao Miyabayashi, Satoru Miura, Hiroshi Tanaka, Tetsuya Abe, Masaaki Okajima, Masaki Terada, Takashi Ishida, Akira Iwashima, Kazuhiro Sato, Hirohisa Yoshizawa, Toshiaki Kikuchi

Cancer medicine, 9(9) 3070-3077, May, 2020
Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastases.

Yu Saida, Satoshi Watanabe, Tetsuya Abe, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Kenichi Koyama, Satoru Miura, Hiroshi Tanaka, Masaaki Okajima, Masaki Terada, Takashi Ishida, Hiroki Tsukada, Masato Makino, Akira Iwashima, Kazuhiro Sato, Naoya Matsumoto, Hirohisa Yoshizawa, Toshiaki Kikuchi

Thoracic cancer, 10(11) 2106-2116, Nov, 2019
Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations.

Miyuki Sato, Satoshi Watanabe, Hiroshi Tanaka, Koichiro Nozaki, Masashi Arita, Miho Takahashi, Satoshi Shoji, Kosuke Ichikawa, Rie Kondo, Nobumasa Aoki, Masachika Hayashi, Yasuyoshi Ohshima, Toshiyuki Koya, Riuko Ohashi, Yoichi Ajioka, Toshiaki Kikuchi

PloS one, 14(4) e0215292, 2019
Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.

Tomohiro Tanaka, Satoshi Watanabe, Miho Takahashi, Ko Sato, Yu Saida, Junko Baba, Masashi Arita, Miyuki Sato, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Nobumasa Aoki, Yasuyoshi Ohshima, Takuro Sakagami, Tetsuya Abe, Hiroshi Moro, Toshiyuki Koya, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Toshiaki Kikuchi

PloS one, 12(8) e0183976, 2017
Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.

Ko Sato, Satoshi Watanabe, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Tomohiro Tanaka, Koichiro Nozaki, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Takuro Sakagami, Toshiyuki Koya, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita

BMC cancer, 16 222-222, Mar 15, 2016
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.

Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Ko Sato, Satoshi Shoji, Natsue Igarashi, Rie Kondo, Masaaki Okajima, Jun Koshio, Kosuke Ichikawa, Koichiro Nozaki, Daisuke Ishikawa, Toshiyuki Koya, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Koh Nakata, Ichiei Narita

Journal of immunology (Baltimore, Md. : 1950), 195(2) 726-35, Jul 15, 2015
Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.

Satoru Miura, Hiroshi Kagamu, Takehito Sakai, Koichiro Nozaki, Katsuaki Asakawa, Hiroshi Moro, Masaaki Okajima, Satoshi Watanabe, Suguru Yamamoto, Noriaki Iino, Shin Goto, Junichiro James Kazama, Hirohisa Yoshizawa, Ichiei Narita

Internal medicine (Tokyo, Japan), 54(1) 55-8, 2015
DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations

Koichiro Nozaki, Hiroshi Kagamu, Satoshi Shoji, Natsue Igarashi, Aya Ohtsubo, Masaaki Okajima, Satoru Miura, Satoshi Watanabe, Hirohisa Yoshizawa, Ichiei Narita

PLoS ONE, 9(10) e111019-e111019, Oct 24, 2014 Peer-reviewedLead author
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

Junko Baba, Satoshi Watanabe, Yu Saida, Tomohiro Tanaka, Takao Miyabayashi, Jun Koshio, Kosuke Ichikawa, Koichiro Nozaki, Toshiyuki Koya, Katsuya Deguchi, Chunrui Tan, Satoru Miura, Hiroshi Tanaka, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ko Nakata, Ichiei Narita

Blood, 120(12) 2417-27, Sep 20, 2012

Books and Other Publications

肺癌薬物療法のエビデンスとコツ

(Role: Joint author, 第6章小細胞肺癌「１．進展型のファーストライン」)

株式会社羊土社, Nov, 2018
エビデンスに基づいた癌化学療法ハンドブック 2018

大津敦総監修 (Role: Joint author, 非小細胞肺癌「CBDCA+Nab-PTX」p142-144)

株式会社メディカルレビュー社, Jun, 2018
肺がん支持療法マニュアル

山本信之監修 (Role: Joint author, ４．神経障害 p60-62)

株式会社医薬ジャーナル, Oct, 2017

Presentations

Effectiveness of afatinib in an NSCLC patitent with EGFR mutation and primary resistance to osimertinib

Feb 18, 2021

Profile Information

Research Interests

Research Areas

Research History

Education

Awards

Papers

Books and Other Publications

Presentations

Professional Memberships

Menu